It's interesting to note that before PSSD, I used to have OCD and treatment-resistant anxiety that only responded to high dose alprazolam. OCD is closely linked to excessive glutamate firing (esp. cortical area), since glutamate modulators offer a rapid anti-obsessional effect, unlike SSRIs. I also used to be overly-emotional and hypersexual.
After PSSD, I have severe treatment-resistant blunted affect, anhedonia, complete absence of anxiety and OCD. My blunted affect somewhat responds to glutamate modulation (NAC, aspartic acid, Baclofen rebound, GABA-A negative allosteric modulation, etc).
5HT2A forms a heterocomplex with mGluR2, as such that 5HT2A agonism (via psychedelic 5HT2A agonism) would inhibit mGluR2 firing. Non-psychedelic 5HT2A agonists (Lisuride, serotonin, etc) don't cause alteration of mGluR2 firing.
mGlu2 receptors are autoreceptors for glutamate. Inhibition of those receptors causes glutamate neurotransmission enhancement, leading to disinhibition of various brain regulatory circuits, enhancing monoamine transmission, and ultimately inducing hallucinations.
N-acetylcysteine (NAC) stimulates the glial cystine/glutamate exchanger and leads to elevated extracellular glutamate levels. This activates mGluR2 (inhibitory), resulting in lessened glutamate release. At high doses, there's a spillover effect that could result in NMDA receptor activation. NAC would probably blunt all psychedelic effects, therefore.
But less about that. Let's get back to how serotonin affects this system:
Serotonin modulates glutamate neurotransmission through the 5-HT1A, 5-HT1B, 5-HT3, 5-HT2, and 5-HT7 receptors.
5-HT1A: It's of extreme importance to differentiate between the 2 types of 5HT1A receptors when reading scientific papers. There are presynaptic autoreceptors that are present on midbrain raphe nuclei, and there are postsynaptic heteroceptors present on the hippocampus, amygdala, cortical and limbic areas. The presynaptic receptors inhibit seronergic neurotransmission whilst postsynaptic ones have a drastically different function.
Regarding glutamate modulation, their activation either increases or decreases glutamate neurotransmission depending on brain area. For example, cortical and hippocampal 5HT1A are localized on GABAergic neurons, so their stimulation would inhibit those neurons, resulting in glutamate disinhibition and increased neuronal firing.
EDIT: Seems I was wrong in this regard:
sylv wrote:In the cortex most of them are located postsynapically, on the glutaminergic pyramidal neurons (up to 80% in some layers in humans ) , much lower on GABAergic interneurons ( around 20% - 30% ) and fast spiking parvalbumin interneurons ( average 5 - 10 %, max 30% ) . The overall effect of their activation is a general hyperpolarization state, reduction of neuronal firing and excitability / inhibition coefficient in this area, clearly visible by direct electrophysiological recording or even in the intensity of fMRI's BOLD effect. Along it goes reduced overall glutaminergic transmission. Hence the antidepressant, antianxiety effects of the full 5-ht1a agonists. They should be avoided for those suffering emotional blunting
Whole brain 5-ht1a mRNA in humans
https://bit.ly/2Vn8J0z
5-HT1a expression human Prefrontal Cortex
https://bit.ly/2WHZl87
5HT1B/1D: These receptors are closely linked to OCD (and glutamate). Stimulation of these receptors facilitate glutamatergic transmission. Chronic SRI intake downregulates these receptors and improve OCD symptoms by dampening of glutamate.
5HT2: I already mentioned 2A. Regarding 5HT2C, activation of that receptor blunts glutamate transmission. Since 5HT2C plays a role in penile erection, outright antagonism or downregulation would be counterproductive for erectile dysfunction, so a partial agonist with a low intrinsic activity would be idea, I reckon.
5HT3: Activation of this receptor is inhibitory to glutamate transmission. 5HT3 antagonism reduces prolactin and enhances glutamate transmission.
5HT7: Activation of this receptor inhibits cortical and hippocampal glutamate transmission. That's why 5HT7 antagonists have antidepressant effect coupled with memory-enhancing effect as well.
My opinion: Direct agonism or antagonism of 5HT1 receptors cause downregulation and upregulation of those receptors, respectively. 5HT2 receptors downregulate in response to both agonism and antagonism (inverse agonism), whilst 5HT3 receptors upregulates in response to both agonism and antagonism at least in-vitro.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543613/
Even 5HT7 receptors might upregulate in response to agonism. https://www.sciencedirect.com/science/a ... 6117301584
Since 5HT receptor subtypes behave this way, a partial agonist with low intrinsic activity (similar to a silent antagonist) would be a more viable long-term solution, since partial agonism doesn't trigger transcriptional adaptation.
Bottomline: If PSSD is related to reduced SERT mRNA expression and 5HT1A-GIRK decoupling, then the abnormally elevated serotonin is dampening our glutamate transmission excessively, causing some of the symptoms. And since some receptors behave differently regarding ligands when it comes to regulation, then we may have abnormally elevated 5HT7/3 receptor density, and abnormally reduced 5HT2 and 5HT1 receptors densities, across different brain areas.
I haven't provided many references as I've typed this thread from memory, since my spare time is very limited. So feel free to double-check.